{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:46:35Z","timestamp":1794588395794,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA273357"],"award-info":[{"award-number":["R01CA273357"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA46595"],"award-info":[{"award-number":["R01CA46595"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA301410"],"award-info":[{"award-number":["R01CA301410"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA273357"],"award-info":[{"award-number":["R01CA273357"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA46595"],"award-info":[{"award-number":["R01CA46595"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA273357"],"award-info":[{"award-number":["R01CA273357"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA273357"],"award-info":[{"award-number":["R01CA273357"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001642","name":"Glenn Foundation for Medical Research","doi-asserted-by":"publisher","award":["Postdoc fellowship"],"award-info":[{"award-number":["Postdoc fellowship"]}],"id":[{"id":"10.13039\/100001642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["K99AG084860"],"award-info":[{"award-number":["K99AG084860"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK135816-01"],"award-info":[{"award-number":["DK135816-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK135816-01"],"award-info":[{"award-number":["DK135816-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK132244"],"award-info":[{"award-number":["DK132244"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK132244"],"award-info":[{"award-number":["DK132244"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA46595"],"award-info":[{"award-number":["R01CA46595"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA46595"],"award-info":[{"award-number":["R01CA46595"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM051405"],"award-info":[{"award-number":["R01GM051405"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Enhanced cholesterol synthesis and lipid droplet accumulation are hallmarks of aggressive prostate cancer, yet how tumour cells sense metabolic inputs to dynamically regulate cholesterol homeostasis remains poorly defined. Here we uncover a metabolic signalling mechanism in which prostate cancer cells remodel propionyl-CoA metabolism to support stress adaptation during disease progression. We show that the catabolism of branched-chain amino acid, specifically isoleucine and valine, is the primary source of intracellular propionyl-CoA in prostate cancer cells. Beyond its metabolic role, propionyl-CoA functions as a signalling molecule that stabilizes nuclear sterol regulatory element-binding protein 2 (SREBP2) through site-specific lysine propionylation, thereby enhancing its transcriptional activity. This activation promotes cholesterol biosynthesis, fuels de novo androgen production, and sustains androgen receptor signalling under metabolic and therapeutic stress, including androgen deprivation. Together, our findings establish propionyl-CoA as a key metabolic signal linking amino acid catabolism to cholesterol-driven oncogenic programmes and highlight targeting isoleucine and valine metabolism as a potential strategy to disrupt lipid reprogramming in prostate cancer.<\/jats:p>","DOI":"10.1038\/s42255-026-01583-z","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:03:01Z","timestamp":1787238181000},"page":"1772-1790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Isoleucine and valine promote prostate cancer progression via propionyl-CoA-mediated cholesterol metabolism"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-9218","authenticated-orcid":false,"given":"Zhongchi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2451-6675","authenticated-orcid":false,"given":"Shuchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayah","family":"Bullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-4579","authenticated-orcid":false,"given":"Xuanrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-3565","authenticated-orcid":false,"given":"Un In","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Owiredu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhucui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-6302","authenticated-orcid":false,"given":"Jennifer","family":"Endress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moniquetta","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Koundouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7227-4591","authenticated-orcid":false,"given":"Chun-Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-2337","authenticated-orcid":false,"given":"John","family":"Blenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"1583_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"1583_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","volume":"18","author":"KT Schmidt","year":"2021","unstructured":"Schmidt, K. T., Huitema, A. D. R., Chau, C. H. & Figg, W. D. Resistance to second-generation androgen receptor antagonists in prostate cancer. Nat. Rev. Urol. 18, 209\u2013226 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"1583_CR3","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1038\/s41388-023-02836-x","volume":"42","author":"X Liu","year":"2023","unstructured":"Liu, X., Lv, M., Zhang, W. & Zhan, Q. Dysregulation of cholesterol metabolism in cancer progression. Oncogene 42, 3289\u20133302 (2023).","journal-title":"Oncogene"},{"key":"1583_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","volume":"131","author":"M Pujana-Vaquerizo","year":"2024","unstructured":"Pujana-Vaquerizo, M., Bozal-Basterra, L. & Carracedo, A. Metabolic adaptations in prostate cancer. Br. J. Cancer 131, 1250\u20131262 (2024).","journal-title":"Br. J. Cancer"},{"key":"1583_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1073\/pnas.1808834116","volume":"116","author":"G Zadra","year":"2019","unstructured":"Zadra, G. et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer. Proc. Natl Acad. Sci. USA 116, 631\u2013640 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1583_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25325-9","volume":"12","author":"C Kalogirou","year":"2021","unstructured":"Kalogirou, C. et al. MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer. Nat. Commun. 12, 5066 (2021).","journal-title":"Nat. Commun."},{"key":"1583_CR7","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1158\/0008-5472.CAN-16-0903","volume":"76","author":"KH Stopsack","year":"2016","unstructured":"Stopsack, K. H. et al. Cholesterol metabolism and prostate cancer lethality. Cancer Res. 76, 4785\u20134790 (2016).","journal-title":"Cancer Res."},{"key":"1583_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo, J., Yang, H. & Song, B.-L. Mechanisms and regulation of cholesterol homeostasis. Nat. Rev. Mol. Cell Biol. 21, 225\u2013245 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1583_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1194\/jlr.C066712","volume":"57","author":"BB Madison","year":"2016","unstructured":"Madison, B. B. Srebp2: a master regulator of sterol and fatty acid synthesis. J. Lipid Res. 57, 333\u2013335 (2016).","journal-title":"J. Lipid Res."},{"key":"1583_CR10","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","volume":"55","author":"M Xiao","year":"2023","unstructured":"Xiao, M. et al. Functional significance of cholesterol metabolism in cancer: from threat to treatment. Exp. Mol. Med. 55, 1982\u20131995 (2023).","journal-title":"Exp. Mol. Med."},{"key":"1583_CR11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.cmet.2022.10.008","volume":"34","author":"M Picard","year":"2022","unstructured":"Picard, M. & Shirihai, O. S. Mitochondrial signal transduction. Cell Metab. 34, 1620\u20131653 (2022).","journal-title":"Cell Metab."},{"key":"1583_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","volume":"7","author":"S Shang","year":"2022","unstructured":"Shang, S., Liu, J. & Hua, F. Protein acylation: mechanisms, biological functions and therapeutic targets. Signal Transduct. Target. Ther. 7, 396 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1583_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova, M. & Akhtar, A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 23, 329\u2013349 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1583_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.molcel.2021.11.006","volume":"82","author":"S Trefely","year":"2022","unstructured":"Trefely, S. et al. Quantitative subcellular acyl-CoA analysis reveals distinct nuclear metabolism and isoleucine-dependent histone propionylation. Mol. Cell 82, 447\u2013462.e6 (2022).","journal-title":"Mol. Cell"},{"key":"1583_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-020-2630-0","volume":"585","author":"AP Gomes","year":"2020","unstructured":"Gomes, A. P. et al. Age-induced accumulation of methylmalonic acid promotes tumour progression. Nature 585, 283\u2013287 (2020).","journal-title":"Nature"},{"key":"1583_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33862-0","volume":"13","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression. Nat. Commun. 13, 6239 (2022).","journal-title":"Nat. Commun."},{"key":"1583_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s42255-022-00553-5","volume":"4","author":"AP Gomes","year":"2022","unstructured":"Gomes, A. P. et al. Altered propionate metabolism contributes to tumour progression and aggressiveness. Nat. Metab. 4, 435\u2013443 (2022).","journal-title":"Nat. Metab."},{"key":"1583_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cmet.2025.01.005","volume":"37","author":"M Shafer","year":"2025","unstructured":"Shafer, M., Low, V., Li, Z. & Blenis, J. The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer. Cell Metab. 37, 316\u2013329 (2025).","journal-title":"Cell Metab."},{"key":"1583_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/JCI66666","volume":"123","author":"C Cai","year":"2013","unstructured":"Cai, C. et al. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. J. Clin. Invest. 123, 1109\u20131122 (2013).","journal-title":"J. Clin. Invest."},{"key":"1583_CR20","doi-asserted-by":"publisher","first-page":"43035","DOI":"10.18632\/oncotarget.17428","volume":"8","author":"MA Jhun","year":"2017","unstructured":"Jhun, M. A. et al. Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. Oncotarget 8, 43035\u201343047 (2017).","journal-title":"Oncotarget"},{"key":"1583_CR21","doi-asserted-by":"publisher","first-page":"15810","DOI":"10.3390\/ijms242115810","volume":"24","author":"Y-H Lee","year":"2023","unstructured":"Lee, Y.-H. & Park, S. Genetic and lifestyle-related factors influencing serum hyper-propionylcarnitine concentrations and their association with metabolic syndrome and cardiovascular disease risk. Int. J. Mol. Sci. 24, 15810 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1583_CR22","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/ijms22041805","volume":"22","author":"R Ikari","year":"2021","unstructured":"Ikari, R. et al. Differences in the central energy metabolism of cancer cells between conventional 2D and novel 3D culture systems. Int. J. Mol. Sci. 22, 1805 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1583_CR23","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1073\/pnas.1705304114","volume":"114","author":"W Eid","year":"2017","unstructured":"Eid, W. et al. mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells. Proc. Natl Acad. Sci. USA 114, 7999\u20138004 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1583_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1152\/physrev.2000.80.1.361","volume":"80","author":"GJ Schroepfer","year":"2000","unstructured":"Schroepfer, G. J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80, 361\u2013554 (2000).","journal-title":"Physiol. Rev."},{"key":"1583_CR25","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/nsmb.3490","volume":"24","author":"AF Kebede","year":"2017","unstructured":"Kebede, A. F. et al. Histone propionylation is a mark of active chromatin. Nat. Struct. Mol. Biol. 24, 1048\u20131056 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1583_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrm.2016.140","volume":"18","author":"BR Sabari","year":"2017","unstructured":"Sabari, B. R., Zhang, D., Allis, C. D. & Zhao, Y. Metabolic regulation of gene expression through histone acylations. Nat. Rev. Mol. Cell Biol. 18, 90\u2013101 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1583_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-62703-646-7_6","volume":"1079","author":"F Sievers","year":"2014","unstructured":"Sievers, F. & Higgins, D. G. Clustal Omega, accurate alignment of very large numbers of sequences. Methods Mol. Biol. 1079, 105\u2013116 (2014).","journal-title":"Methods Mol. Biol."},{"key":"1583_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.urolonc.2022.10.018","volume":"41","author":"M Shiota","year":"2023","unstructured":"Shiota, M., Endo, S., Blas, L., Fujimoto, N. & Eto, M. Steroidogenesis in castration-resistant prostate cancer. Urol. Oncol. 41, 240\u2013251 (2023).","journal-title":"Urol. Oncol."},{"key":"1583_CR29","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1038\/s41388-021-02008-9","volume":"40","author":"E Labanca","year":"2021","unstructured":"Labanca, E. et al. Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel. Oncogene 40, 6284\u20136298 (2021).","journal-title":"Oncogene"},{"key":"1583_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","volume":"19","author":"S Yue","year":"2014","unstructured":"Yue, S. et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 19, 393\u2013406 (2014).","journal-title":"Cell Metab."},{"key":"1583_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mce.2008.08.013","volume":"295","author":"PR Dillard","year":"2008","unstructured":"Dillard, P. R., Lin, M.-F. & Khan, S. A. Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Mol. Cell. Endocrinol. 295, 115\u2013120 (2008).","journal-title":"Mol. Cell. Endocrinol."},{"key":"1583_CR32","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"F R\u00f6hrig","year":"2016","unstructured":"R\u00f6hrig, F. & Schulze, A. The multifaceted roles of fatty acid synthesis in cancer. Nat. Rev. Cancer 16, 732\u2013749 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1583_CR33","doi-asserted-by":"publisher","first-page":"1206561","DOI":"10.3389\/fonc.2023.1206561","volume":"13","author":"CL Lines","year":"2023","unstructured":"Lines, C. L., McGrath, M. J., Dorwart, T. & Conn, C. S. The integrated stress response in cancer progression: a force for plasticity and resistance. Front. Oncol. 13, 1206561 (2023).","journal-title":"Front. Oncol."},{"key":"1583_CR34","doi-asserted-by":"publisher","first-page":"14917","DOI":"10.3390\/ijms232314917","volume":"23","author":"EA Castell\u00f3n","year":"2022","unstructured":"Castell\u00f3n, E. A., Indo, S. & Contreras, H. R. Cancer stemness\/epithelial-mesenchymal transition axis influences metastasis and castration resistance in prostate cancer: potential therapeutic target. Int. J. Mol. Sci. 23, 14917 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1583_CR35","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1158\/1541-7786.MCR-18-1147","volume":"17","author":"KD Tousignant","year":"2019","unstructured":"Tousignant, K. D. et al. Lipid uptake is an androgen-enhanced lipid supply pathway associated with prostate cancer disease progression and bone metastasis. Mol. Cancer Res. MCR 17, 1166\u20131179 (2019).","journal-title":"Mol. Cancer Res. MCR"},{"key":"1583_CR36","doi-asserted-by":"publisher","first-page":"30880","DOI":"10.1074\/jbc.M401615200","volume":"279","author":"H Heemers","year":"2004","unstructured":"Heemers, H. et al. Identification of an androgen response element in intron 8 of the sterol regulatory element-binding protein cleavage-activating protein gene allowing direct regulation by the androgen receptor. J. Biol. Chem. 279, 30880\u201330887 (2004).","journal-title":"J. Biol. Chem."},{"key":"1583_CR37","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1158\/0008-5472.CAN-2148-2","volume":"64","author":"SL Ettinger","year":"2004","unstructured":"Ettinger, S. L. et al. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res. 64, 2212\u20132221 (2004).","journal-title":"Cancer Res."},{"key":"1583_CR38","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1128\/MCB.23.7.2587-2599.2003","volume":"23","author":"V Giandomenico","year":"2003","unstructured":"Giandomenico, V., Simonsson, M., Gr\u00f6nroos, E. & Ericsson, J. Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol. Cell. Biol. 23, 2587\u20132599 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"1583_CR39","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1038\/s41388-024-03148-4","volume":"43","author":"S Sardar","year":"2024","unstructured":"Sardar, S. et al. AR coactivators, CBP\/p300, are critical mediators of DNA repair in prostate cancer. Oncogene 43, 3197\u20133213 (2024).","journal-title":"Oncogene"},{"key":"1583_CR40","doi-asserted-by":"publisher","unstructured":"Demetriadou, C. et al. A nuclear branched-chain amino acid catabolism pathway controls histone propionylation in pancreatic cancer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.04.23.650241 (2025).","DOI":"10.1101\/2025.04.23.650241"},{"key":"1583_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41391-022-00554-1","volume":"25","author":"EL Craig","year":"2022","unstructured":"Craig, E. L. et al. Statins and prostate cancer-hype or hope? The epidemiological perspective. Prostate Cancer Prostatic Dis. 25, 641\u2013649 (2022).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1583_CR42","doi-asserted-by":"publisher","first-page":"e2242676","DOI":"10.1001\/jamanetworkopen.2022.42676","volume":"5","author":"VH Jayalath","year":"2022","unstructured":"Jayalath, V. H. et al. Statin use and survival among men receiving androgen-ablative therapies for advanced prostate cancer: a systematic review and meta-analysis. JAMA Netw. Open 5, e2242676 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1583_CR43","doi-asserted-by":"publisher","first-page":"12869","DOI":"10.18632\/oncotarget.7331","volume":"7","author":"X Li","year":"2016","unstructured":"Li, X. et al. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget 7, 12869\u201312884 (2016).","journal-title":"Oncotarget"},{"key":"1583_CR44","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch, C. J. & Adams, S. H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10, 723\u2013736 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1583_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06893-2","volume":"15","author":"CL Bidgood","year":"2024","unstructured":"Bidgood, C. L. et al. Targeting valine catabolism to inhibit metabolic reprogramming in prostate cancer. Cell Death Dis. 15, 513 (2024).","journal-title":"Cell Death Dis."},{"key":"1583_CR46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.cmet.2021.03.025","volume":"33","author":"D Yu","year":"2021","unstructured":"Yu, D. et al. The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. Cell Metab. 33, 905\u2013922.e6 (2021).","journal-title":"Cell Metab."},{"key":"1583_CR47","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.ccell.2025.05.003","volume":"43","author":"JC Knol","year":"2025","unstructured":"Knol, J. C. et al. The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets. Cancer Cell 43, 1328\u20131346.e8 (2025).","journal-title":"Cancer Cell"},{"key":"1583_CR48","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jhep.2022.11.017","volume":"78","author":"J Sun","year":"2023","unstructured":"Sun, J. et al. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J. Hepatol. 78, 627\u2013642 (2023).","journal-title":"J. Hepatol."},{"key":"1583_CR49","doi-asserted-by":"publisher","first-page":"109625","DOI":"10.1016\/j.celrep.2021.109625","volume":"36","author":"I Grbesa","year":"2021","unstructured":"Grbesa, I. et al. Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity. Cell Rep. 36, 109625 (2021).","journal-title":"Cell Rep."},{"key":"1583_CR50","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost, J. et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat. Protoc. 11, 347\u2013358 (2016).","journal-title":"Nat. Protoc."},{"key":"1583_CR51","doi-asserted-by":"publisher","first-page":"jcs213710","DOI":"10.1242\/jcs.213710","volume":"131","author":"S Xu","year":"2018","unstructured":"Xu, S., Liu, Y., Meng, Q. & Wang, B. Rab34 small GTPase is required for Hedgehog signaling and an early step of ciliary vesicle formation in mouse. J. Cell Sci. 131, jcs213710 (2018).","journal-title":"J. Cell Sci."},{"key":"1583_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jchromb.2017.08.020","volume":"1063","author":"Y Satomi","year":"2017","unstructured":"Satomi, Y., Hirayama, M. & Kobayashi, H. One-step lipid extraction for plasma lipidomics analysis by liquid chromatography mass spectrometry. J. Chromatogr. B 1063, 93\u2013100 (2017).","journal-title":"J. Chromatogr. B"},{"key":"1583_CR53","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa, H. et al. MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis. Nat. Methods 12, 523\u2013526 (2015).","journal-title":"Nat. Methods"},{"key":"1583_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66558-2","volume":"16","author":"Z Zhu","year":"2025","unstructured":"Zhu, Z. et al. A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1. Nat. Commun. 16, 10611 (2025).","journal-title":"Nat. Commun."},{"key":"1583_CR55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1583_CR56","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511\u2013515 (2010).","journal-title":"Nat. Biotechnol."},{"key":"1583_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nbt.2450","volume":"31","author":"C Trapnell","year":"2013","unstructured":"Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46\u201353 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1583_CR58","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"1583_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1583_CR60","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41591-018-0241-1","volume":"24","author":"M Rotinen","year":"2018","unstructured":"Rotinen, M. et al. ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis. Nat. Med. 24, 1887\u20131898 (2018).","journal-title":"Nat. Med."},{"key":"1583_CR61","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/s42255-023-00817-8","volume":"5","author":"E Benedetti","year":"2023","unstructured":"Benedetti, E. et al. A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation. Nat. Metab. 5, 1029\u20131044 (2023).","journal-title":"Nat. Metab."},{"key":"1583_CR62","doi-asserted-by":"publisher","unstructured":"Zhongchi, L. Serum metabolomic profiling of nude mice fed an isoleucine- and valine-restricted diet. Zenodo https:\/\/doi.org\/10.5281\/zenodo.21047050 (2026).","DOI":"10.5281\/zenodo.21047050"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01583-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:02:11Z","timestamp":1790172131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01583-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1583"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01583-z","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zhongchi Li, J.B. and N.K. are the founders of Elikia Inc., which targets ageing-related metabolic dysfunction for the treatment of ageing-related diseases. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}